A highly sensitive flow cytometry test that looks for minimal residual disease (MRD) — very small numbers of remaining cancer cells — in Myelodysplastic Syndrome (MDS).
Shows how deeply the disease has responded to treatment, helps predict relapse and guides further treatment decisions.
People being evaluated or treated for cancer, or as advised by an oncologist. Not a stand-alone screening test.
No fasting needed.
This article is for general information and education only. It is not medical advice, does not create a doctor–patient relationship, and is not a substitute for consultation with a qualified doctor who has assessed your individual situation. Never delay seeking medical advice because of something you have read here.
In a medical emergency, call 112, or 108 for an ambulance where that service operates, or go to your nearest emergency department. If you are in mental health distress, Tele-MANAS is free and available 24×7 on 14416.
Read our Editorial Policy and Medical Review Process.
No fasting is needed. You can eat and drink normally unless your doctor has advised otherwise.
Blood or bone marrow sample (EDTA/heparin tube) as advised by your haematologist.
Usually within 4–5 days after the sample reaches the lab. You will receive the report online.